Evogene EVGN
NASDAQ EVGN
$0.56 +0.00 (+0.36%)
At close: Aug 21, 2026 · 4:00 PM EDT

Evogene (EVGN) Change in Acquisitions & Divestments (2013 - 2025)

Evogene (EVGN) posted Change in Acquisitions & Divestments of -$1.0 million for Q2 2025, up 56.92% sequentially from -$2.3 million in Q1 2025, and down 115.5% YoY from $6.5 million in Q2 2024.

Evogene (EVGN) Change in Acquisitions & Divestments (2013 - 2025) Analysis & Trends

Evogene has reported Change in Acquisitions & Divestments for 13 years, with the latest figure at -$1.0 million in Q2 2025.

  • Quarterly Change in Acquisitions & Divestments fell 115.5% year-over-year to -$1.0 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $7.9 million (up 79.11% YoY) and the FY2024 annual result came in at $27.3 million, up 294.86% from the prior year.
  • Change in Acquisitions & Divestments improved to -$1.0 million in Q2 2025 per EVGN's latest filing, from -$2.3 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $9.4 million in Q1 2022 and troughed at -$5.4 million in Q1 2024.
  • A 5-year average of $2.0 million and a median of $624000.0 in 2021 frame the typical range for Change in Acquisitions & Divestments.
  • The sharpest annual moves came in 2022 and 2023: Change in Acquisitions & Divestments surged 942500.0% in 2022, then tumbled 12600.0% in 2023.
  • Over 5 years, Change in Acquisitions & Divestments stood at $3.4 million in 2021, then sank by 99.88% to $4000.0 in 2022, then sank by 12600.0% to -$500000.0 in 2023, then jumped by 1916.0% to $9.1 million in 2024, then slumped by 111.04% to -$1.0 million in 2025.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered -$1.0 million, -$2.3 million, and $9.1 million for Q2 2025, Q1 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Evogene 4.38 Mn 4.38 Mn 204,000.00

Historic Data

Download Data
DateValue
Jun 30, 2025 -1.00 Mn
Jun 30, 2025 -1.00 Mn
Mar 31, 2025 -2.33 Mn
Mar 31, 2025 -2.33 Mn
Dec 31, 2024 9.08 Mn
Dec 31, 2024 9.08 Mn
Sep 30, 2024 2.10 Mn
Sep 30, 2024 2.10 Mn
Jun 30, 2024 6.47 Mn
Jun 30, 2024 6.47 Mn
Mar 31, 2024 -5.44 Mn
Mar 31, 2024 -5.44 Mn
Dec 31, 2023 -500,000.00
Dec 31, 2023 -500,000.00
Sep 30, 2023 3.86 Mn
Sep 30, 2023 3.86 Mn
Jun 30, 2023 6.29 Mn
Jun 30, 2023 6.29 Mn
Mar 31, 2023 637,000.00
Mar 31, 2023 637,000.00